More than 200 jobs will be created through a £4.6m investment in revamping laboratory space at Charnwood Campus. Highly-specialised lab space, which is currently unused, is to be reactivated to create a world-class biochemistry building. The project will enable a research organisation to expand into the LLEP area. And it will mean existing facilities can … Read more
Charnwood Campus has recommissioned its world-class synthetic and chemistry research facility to the highest standard to cater to the needs of its newest occupier and leading pre-clinical discovery contract research organisation (CRO) Charnwood Molecular, in a £54m construction project. The three-storey, state-of-the-art synthetic and chemistry research facility has been fully modernised by engineering firm … Read more
Leading UK pre-clinical discovery CRO servicing the global pharmaceutical and biotechnology market, Charnwood Molecular, has joined Charnwood Campus and expanded its operations in a deal expected to support the growth of its contract research services. Charnwood Molecular continues to build upon its foundation in medicinal chemistry, scale-up chemistry and custom synthesis provision, evolving its … Read more
Global contract development and manufacturing organisation (CDMO) Kindeva Drug Delivery has expanded its operations at Charnwood Campus, in a deal expected to support Kindeva’s continued growth in the UK. The US-headquartered company will take over a state-of-the-art research and development facility at Charnwood Campus, and a further 20,000 square feet of office space at the … Read more